International Media Acquisition Corp. Finalizes Restructured $1 Billion Merger Agreement with VCI Holdings

summarizeSummary

International Media Acquisition Corp. (IMAQ) has signed a definitive, restructured merger agreement with VCI Holdings Limited and Valix Limited, providing a path to complete its business combination and avoid liquidation, despite significant dilution for existing shareholders.

check_boxKey Events

• Restructured Merger Agreement Signed

  IMAQ entered into an amended and restated merger agreement on April 30, 2026, with VCI Holdings Limited, Valix Limited (Purchaser), and other entities, replacing the original April 2025 agreement.

• Significant Share Issuance

  The Purchaser will issue 100,000,000 ordinary shares to VCI shareholders, 2,536,310 additional shares, and various commitment shares (e.g., 1,128,100 shares to Polar Asset Management Partners) as part of the transaction.

• Performance-Based Earnout

  Up to an additional 27,000,000 Purchaser Class A Ordinary Shares may be issued to Earnout Shareholders based on future performance targets, including a $15.00 VWAP, $500 million in revenue, or a $20 million dividend.

• SPAC Survival & Redomestication

  The agreement provides a definitive path for IMAQ to complete its business combination, avoiding liquidation, and includes a reincorporation merger where IMAQ becomes a subsidiary of Valix Limited, followed by redomestication to the British Virgin Islands.

auto_awesomeAnalysis

International Media Acquisition Corp. (IMAQ), a SPAC facing severe financial distress, has entered into a definitive amended and restated merger agreement with VCI Holdings Limited and its subsidiaries, Valix Limited (Purchaser), and Newbio Merger Limited. This agreement, dated April 30, 2026, provides a critical path for IMAQ to complete its business combination and avoid potential liquidation, a significant positive given its previously disclosed 'going concern warning' and 'zero cash' position. The transaction involves a complex restructuring where IMAQ will become a wholly-owned subsidiary of Valix Limited, which will acquire VCI Holdings. While offering a lifeline, the deal is highly dilutive for existing IMAQ shareholders, with over 100 million new shares to be issued to VCI shareholders and others, plus up to 27 million performance-based earnout shares, significantly increasing the share count compared to IMAQ's current 6.8 million outstanding shares. The combined entity will also undergo redomestication to the British Virgin Islands and aims for a Nasdaq listing, signaling a new chapter for the company.